Neisseria meningitidis sequence type and risk for death, Iceland

Emerging Infectious Diseases

Volumn 12, Issue 7, 2006, Pages 1066-1073

  Gottfreosson, Magnús ^a,b   Diggle, Mathew A ^c   Lawrie, David I ^c   Erlendsdóttir, Helga ^a   Haroardóttir, Hjördís ^a   Kristinsson, Karl G ^a,b   Clarke, Stuart C ^c,d  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c Scottish Meningococcus and Pneumococcus Reference Laboratory   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; DEATH; ENDEMIC DISEASE; FEMALE; HUMAN; ICELAND; MAJOR CLINICAL STUDY; MALE; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; OUTCOME ASSESSMENT; SEQUENCE ANALYSIS;

EID: 33745935762     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1207.051624     Document Type: Article

References (23)

1. Harrison LH, Pass MA, Mendelsohn AB, Egri M, Rosenstein NE, Bustamante A, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286:694-9.
2. Goldacre MJ, Roberts SE, Yeates D. Case fatality rates for meningococcal disease in an English population, 1963-98: database study. BMJ. 2003;327:596-7.
3. Robbins JB, Schneerson R, Gotschlich EC, Mohammed I, Nasidi A, Chippaux JP, et al. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines. Bull World Health Organ. 2003;81:745-50.
4. Peltola H, Jonsdottir K, Lystad A, Sievers CJ, Kallings I. Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed). 1982;284:1618-21.
5. Poolman JT, Lind I, Jonsdottir K, Froholm LO, Jones DM, Zanen HC. Meningococcal serotypes and serogroup B disease in north-west Europe. Lancet. 1986;2:555-8.
6. Yakubu DE, Abadi FJ, Pennington TH. Molecular typing methods for Neisseria meningitidis. J Med Microbiol. 1999;48:1055-64.
7. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998;95:3140-5.
8. Clarke SC, Diggle MA, Edwards GFS. Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J Clin Microbiol. 2001;39:3066-71.
9. Clinical and Laboratory Standards Institute. M100-S15 performance standard for antimicrobial susceptibility testing, 15th informational supplement. Wayne (PA): The Institute; 2005.
10. Diggle MA, Clarke SC. Rapid assignment of nucleotide sequence data to allele types for multi-locus sequence analysis (MLSA) of bacteria using an adapted database and modified alignment program. J Mol Microbiol Biotechnol. 2002;4:515-7.
11. Diggle MA, Clarke SC. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines. J Clin Microbiol. 2005;43:4649-53.
12. Murphy KM, O'Donnell KA, Higgins AB, O'Neill C, Cafferkey MT. Irish strains of Neisseria meningitidis: characterisation using multilocus sequence typing. Br J Biomed Sci. 2003;60:204-9.
13. Takahashi H, Kuroki T, Watanabe Y, Tanaka H, Inouye H, Yamai S, et al. Characterization of Neisseria meningitidis isolates collected from 1974 to 2003 in Japan by multilocus sequence typing. J Med Microbiol. 2004;53:657-62.
14. Pollard AJ, Ochnio J, Ho M, Callaghan M, Bigham M, Dobsong S. Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America. Emerg Infect Dis. 2004;10:1812-5.
15. Canica M, Dias R, Ferreira E, Meningococci Study Group. Neisseria meningitidis C:2b:P1.2,5 with intermediate resistance to penicillin, Portugal. Emerg Infect Dis. 2004;10:526-9.
16. Antignac A, Ducos-Galand M, Guiyoule A, Pires R, Alonso JM, Taha MK. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin Infect Dis. 2003;37:912-20.
17. Saez-Nieto JA, Lujan R, Berron S, Campos J, Vinas M, Fuste C, et al. Epidemiology and molecular basis of penicillin-resistant Neisseria meningitidis in Spain: a 5-year history (1985-1989). Clin Infect Dis. 1992;14:394-402.
18. Rainbow J, Cebelinski E, Bartkus J, Glennen A, Boxrud D, Lynfield R. Rifampin-resistant meningococcal disease. Emerg Infect Dis. 2005;11:977-9.
19. van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-59.
20. Arason VA, Gunnlaugsson A, Sigurdsson JA, Erlendsdottir H, Gudmundsson S, Kristinsson KG. Clonal spread of resistant pneumococci despite diminished antimicrobial use. Microb Drug Resist. 2002;8:187-92.
21. Sandgren A, Albiger B, Orihuela CJ, Tuomanen E, Normark S. Henriques-Normark B. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. J Infect Dis. 2005;192:791-800.
22. Sandgren A, Sjostrom K, Olsson-Liljequist B, Christensson B, Samuelsson A, Kronvall G, et al. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae. J Infect Dis. 2004;189:785-96.
23. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, Urwin R, et al. Genetic analysis of meningococci carried by children and young adults. J Infect Dis. 2005;191:1263-71.